← All medicines
REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
Licence PA23458/004/001 · Not marketed
- Licence holder
- Sanofi Winthrop Industrie (all products →)
- Active substances
- Tetanus toxoid, Diphtheria toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin, Polio virus type 1 inactivated, Polio virus type 2 inactivated, Polio virus type 3 inactivated, Adsorbed aluminium phosphate, Adsorbed fimbriae types 2 + 3
- Dosage form
- Suspension for injection in pre-filled syringe
- Route of administration
- Intravenous use
- ATC codes
- J07CA, J07CA02
- First authorised
- 25/07/2003
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.